StoneRidge PMG Advisors LLC Purchases 2,354 Shares of CME Group Inc. $CME

StoneRidge PMG Advisors LLC purchased a new position in CME Group Inc. (NASDAQ:CME) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 2,354 shares of the financial services provider’s stock, valued at approximately $617,000.

Several other large investors also recently modified their holdings of the company. Whipplewood Advisors LLC lifted its holdings in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 83 shares during the period. First Community Trust NA bought a new stake in shares of CME Group during the 3rd quarter valued at about $26,000. North Point Portfolio Managers Corp OH purchased a new stake in shares of CME Group during the 3rd quarter valued at about $26,000. Main Street Group LTD purchased a new stake in shares of CME Group during the 1st quarter valued at about $32,000. Finally, Compass Financial Management LLC increased its position in shares of CME Group by 471.4% during the 3rd quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 99 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $305.89 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a 50-day simple moving average of $283.10 and a two-hundred day simple moving average of $280.79. The stock has a market cap of $109.49 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 3.73 and a beta of 0.15. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating analysts’ consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.71 billion. During the same period in the previous year, the firm earned $2.68 EPS. The business’s quarterly revenue was up 10.6% on a year-over-year basis. On average, analysts expect that CME Group Inc. will post 12.34 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s dividend payout ratio is currently 42.66%.

Insider Activity at CME Group

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $302.50, for a total value of $121,000.00. Following the completion of the transaction, the director directly owned 25,244 shares in the company, valued at $7,636,310. This represents a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Howard J. Siegel sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $303.00, for a total transaction of $606,000.00. Following the completion of the transaction, the director owned 19,873 shares of the company’s stock, valued at approximately $6,021,519. The trade was a 9.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 32,979 shares of company stock worth $9,552,762 in the last 90 days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Weiss Ratings raised shares of CME Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, October 23rd. Piper Sandler restated an “overweight” rating and set a $330.00 target price (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. UBS Group upped their target price on shares of CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a report on Thursday, October 22nd. CLSA set a $367.00 price target on shares of CME Group in a research report on Thursday, October 22nd. Finally, Barclays increased their price target on shares of CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 22nd. Ten analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $314.44.

CME Group Company Profile

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.

The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

CME Group was formed in 2007 through the merger of the Chicago Mercantile Exchange and the Chicago Board of Trade, institutions with roots in the 19th century.